ML19269C978
| ML19269C978 | |
| Person / Time | |
|---|---|
| Issue date: | 12/27/1978 |
| From: | Hendrie J NRC COMMISSION (OCM) |
| To: | Howton C GENERAL SERVICES ADMINISTRATION |
| References | |
| NUDOCS 7902260004 | |
| Download: ML19269C978 (4) | |
Text
[
- ,"6 UNITED STATES
,4,%
N'
_E AR REGULATORY COMMISSIOi 4
[
A-M fY)
WASmNOTON. D. C. 23555
'1 e"
WQ
\\.,-"./,/.
December 27, 1978
- es*
CH AIR!' AN Mr. Charles F. Howton Cc=ai nee Management Secretariat General Services Administration Washington, D. C. 20450
Dear Mr. Howton:
The charter of the fluclear Regulatory Commission's Advisory Committee on Medical Uses of Isotopes is due to expire on January 31, 1979.
This is to inform you of the Commission's determination regarding renewal of this charter' for the two-year period beginning on February 1,1979.
The Commission has determined that renewal of.the charter ',r the Advisory Committee on Medical Uses of Isotopes is necessary and in the public interest.
There are no physicians or other personnel on NRC's staff with the qualifications and expertise of the Committee members to supply the medical judgments and advice necessary for the agency to make decisions concerning the regulation and licensing of uses of radioisotopes in humans for medical diagnosis, therapy, and research.
Continuation of the Committee is necessary for this agency to obtain advice and consulta-tion on new license applications relating to user qualifications and the human use of radiation sources.
The fiRC's. plan for attaining balanced membership on this Coriittee is to seek and obtain expert advice from those scientific and technical disciplines directly related to the functions to be performed and the points of view to be represented.
At the present time these disciplines include radiology, pathology, internal medicine and medical physics.
The functions of the Advisory Committee on the Medical Uses of Isotopes can not be performed by any other organization within this agency and the necessary advice this Committee provides is not available from other sources within the Commission.
As noted.above, there are no personnel on NRC's staff with the qualifications and expertise represented by the Committee.
Moreover, the cost of the Committee is quite srall compared to the services rendered to fiRC.
At the present time, there apperr to be no other sources in the Advisory Committees of this or other age 1cies which have the necessary expertise to provide the advice recuired in this area.
7902266CO9
10.
Filing date This charter for the advisory committee named above, is hereby approved on (Date)
John C. Hoyle, Advisory Comn:ittee Management Officer 4
~
Mr. Charles F. Howton ' lith your concurrence, we will initiate necessary acticn to publish n;; ice of renewal in the Federai Register, file the charter with the appropriate Congressional Committees, and furnish a copy of the charter to the Library of Congress.
Sincerely, F
Joseph M. Hendrie
Attachment:
Charter for the USNRC Advisory Committee on the Medical Uses of Isotopes 4
.\\.
4 UNITED STATES NUCLEAR REGULATORY C05"4!SS10h CHARTER FOR ADVISORY COMMITTEE JE MEDICAL L'SES OF ISOTOPES (Pursuant to Section 9 of Public Law 92-463) 1 Advisory Comnittee en the Medical Uses of IsotoDes TCommittee's Of ficial Designation) 2.
Committee's objectives scope of activities and duties are as follows:
lho Committee provides advice, as requested by the Director, Division of Fuel Cycle and Material Safety, Office of Nuclear Material Safety and Safeguards, with respect to the development of standards and criteria for the regulation and licensing of uses of radionuclides in human subjects.
The Committee also provides advice and consultation with respect to individual applications on user qualifications and the human use of radiation sources.
3.
Time period (duration) of this Committee:
From February 1, 1979 to February 1, 1981.
4.
Official to whom this Committee reports:
Richard Cunningham Director Division of Fuel Cycle and Material Safety Office of Nuclear Material Safety and Safeguards U.S. Nuclear Regulatory Commission
~
5.
Agency responsibility for providing necessary support to this Committee; U. S. Nuclear Regulatory Commission 6.
The duteis of the Committee are set forth in item 2 above.
7.
Estimated annual direct costs of this Committee:
a.
$10,000 1/
b.
Total man-year of support:
Less than one.
8.
Estimated number of meetings per year: Two 0.
The Ccmmittee's termination date, if less than two years, from the date of establishment or renewal:
Not applicable (See No. 3 above) l/ Total pay and ^other" allowed expenses including travel and per die-consultants.
.